Nandrolone Decanoate (American Regent, Inc.)
Welcome to the PulseAid listing for the Nandrolone Decanoate drug offered from American Regent, Inc.. This Androgen [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | American Regent, Inc. |
NON-PROPRIETARY NAME: | Nandrolone Decanoate |
SUBSTANCE NAME: | NANDROLONE DECANOATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Androgen [EPC] |
ROUTE: | INTRAMUSCULAR |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2000-01-01 |
END MARKETING DATE: | 0000-00-00 |
Nandrolone Decanoate HUMAN PRESCRIPTION DRUG Details:
Item Description | Nandrolone Decanoate from American Regent, Inc. |
LABELER NAME: | American Regent, Inc. |
DEA SCHEDULE: | CIII
|
ACTIVE STRENGTH: | 200(mg/mL) |
START MARKETING DATE: | 2000-01-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0517-0790_a5bf7ff6-bba0-4e86-92d1-9f929fd4794b |
PRODUCT NDC: | 0517-0790 |
APPLICATION NUMBER: | ANDA091252 |
Other NANDROLONE DECANOATE Pharmaceutical Manufacturers / Labelers: